Concord Medical Services (NYSE:CCM) Earns Sell Rating from Analysts at StockNews.com

Research analysts at StockNews.com assumed coverage on shares of Concord Medical Services (NYSE:CCM) in a note issued to investors on Monday. The firm set a “sell” rating on the stock.

Concord Medical Services Trading Up 9.9%

Shares of CCM opened at $8.58 on Monday. Concord Medical Services has a fifty-two week low of $3.80 and a fifty-two week high of $26.70. The company has a 50 day moving average price of $5.25 and a 200-day moving average price of $5.07. The company has a quick ratio of 0.46, a current ratio of 0.47 and a debt-to-equity ratio of 1.15.

About Concord Medical Services

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People's Republic of China. It operates in two segments, Network and Hospital. The company's services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services.